Loading...
IMCD N.V. sells, markets, and distributes specialty chemicals, and pharmaceutical and food ingredients in Europe, the Middle East, Africa, the Asia-Pacific, and the Americas. The last earnings update was 73 days ago. More info.
7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
---|---|---|---|---|---|---|
IMCD (IMCD.Y) | 0% | 0% | 0% | - | - | - |
US Trade Distributors | 3.7% | 7.7% | 7.3% | 18.9% | 44.7% | 22.6% |
US Market | 1.4% | 1.8% | -0.8% | 12.6% | 39.2% | 43% |
Sorry, no analysis for IMCD's competitors could be found in our database.
Is IMCD undervalued based on future cash flows and its price relative to the stock market?
Below are the data sources, inputs and calculation used to determine the intrinsic value for IMCD.
Data Point | Source | Value |
---|---|---|
Valuation Model | 2 Stage Free Cash Flow to Equity | |
Levered Free Cash Flow | Average of 8 Analyst Estimates (S&P Global) | See below |
Discount Rate (Cost of Equity) | See below | 9% |
Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
Data Point | Calculation/ Source | Result |
---|---|---|
Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
Equity Risk Premium | S&P Global | 6% |
Trade Distributors Unlevered Beta | Simply Wall St/ S&P Global | 0.92 |
Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.922 (1 + (1- 25%) (21.74%)) |
1.049 |
Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.05 |
Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.049 * 5.96%) |
8.98% |
Discounted Cash Flow Calculation for OTCPK:IMCD.Y using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for IMCD is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
Note: Free cash flow to equity valuations ignore the company's cash or debt.
Levered FCF (EUR, Millions) | Source |
Present Value Discounted (@ 8.98%) |
|
---|---|---|---|
2020 | 152.00 | Analyst x3 | 139.48 |
2021 | 159.33 | Analyst x3 | 134.16 |
2022 | 165.48 | Est @ 3.85% | 127.85 |
2023 | 171.30 | Est @ 3.52% | 121.44 |
2024 | 176.92 | Est @ 3.28% | 115.09 |
2025 | 182.43 | Est @ 3.12% | 108.90 |
2026 | 187.90 | Est @ 3% | 102.92 |
2027 | 193.39 | Est @ 2.92% | 97.20 |
2028 | 198.92 | Est @ 2.86% | 91.74 |
2029 | 204.54 | Est @ 2.82% | 86.56 |
Present value of next 10 years cash flows | €1,125.00 |
Calculation | Result | |
---|---|---|
Terminal Value |
= FCF2029
× (1 + g) ÷ (Discount Rate – g)
= €204.54 × (1 + 2.73%) ÷ (8.98% – 2.73%) |
€3,361.87 |
Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= €3,361.87 ÷ (1 + 8.98%)10 |
€1,422.69 |
Calculation | Result | |
---|---|---|
Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= €1,125.00 + €1,422.69 |
€2,547.69 |
Equity Value per Share (EUR) |
= Total value / Shares Outstanding
= €2,547.69 / 52.45 |
€48.58 |
Calculation | Result | |
---|---|---|
Non-primary Listing Adjustment Factor |
1 share in OTCPK:IMCD.Y
represents 0.64071x
of
ENXTAM:IMCD
(This could be a different class, a depositary receipt, a different currency, or all of these things.) |
0.64071x |
Value per Share (Listing Adjusted, USD) |
= Value per Share (EUR) x Listing Adjustment Factor
= € 48.58 x 0.64071 |
$31.12 |
Value per share (USD) | From above. | $31.12 |
Current discount | Discount to share price of
$44.85
= -1 x ($44.85 - $31.12) / $31.12 |
-44.1% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Data Point | Source | Value |
---|---|---|
Earnings Per Share * | Company Filings (2019-06-30) in EUR | €2.11 |
ENXTAM:IMCD Share Price ** | ENXTAM (2019-07-30) in EUR | €70 |
United States of America Trade Distributors Industry PE Ratio | Median Figure of 39 Publicly-Listed Trade Distributors Companies | 17.4x |
United States of America Market PE Ratio | Median Figure of 2,947 Publicly-Listed Companies | 17.8x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of IMCD.
Calculation | Outcome | |
---|---|---|
PE Ratio | = ENXTAM:IMCD Share Price ÷ EPS (both in EUR) = 70 ÷ 2.11 |
33.19x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Data Point | Source | Value |
---|---|---|
PE Ratio | See PE Ratio Section | 33.19x |
Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts |
10.8%per year |
United States of America Trade Distributors Industry PEG Ratio | Median Figure of 31 Publicly-Listed Trade Distributors Companies | 1.16x |
United States of America Market PEG Ratio | Median Figure of 2,051 Publicly-Listed Companies | 1.49x |
*Line of best fit is calculated by linear regression .
Calculation | Outcome | |
---|---|---|
PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 33.19x ÷ 10.8% |
3.08x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Data Point | Source | Value |
---|---|---|
Book Value per Share | Company Filings (2019-06-30) in EUR | €15.51 |
ENXTAM:IMCD Share Price * | ENXTAM (2019-07-30) in EUR | €70 |
United States of America Trade Distributors Industry PB Ratio | Median Figure of 52 Publicly-Listed Trade Distributors Companies | 1.69x |
United States of America Market PB Ratio | Median Figure of 5,044 Publicly-Listed Companies | 1.72x |
Calculation | Outcome | |
---|---|---|
PB Ratio | = ENXTAM:IMCD Share Price ÷ Book Value per Share (both in EUR) = 70 ÷ 15.51 |
4.51x |
* Primary Listing of IMCD.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
How is IMCD expected to perform in the next 1 to 3 years based on estimates from 8 analysts?
Data Point | Source | Value (per year) |
---|---|---|
OTCPK:IMCD.Y Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts | 10.8% |
OTCPK:IMCD.Y Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 8 Analysts | 5% |
United States of America Trade Distributors Industry Earnings Growth Rate | Market Cap Weighted Average | 12.8% |
United States of America Trade Distributors Industry Revenue Growth Rate | Market Cap Weighted Average | 4.6% |
United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 14.5% |
United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.2% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Data Point | Source | Value |
---|---|---|
Past Financials | Company Filings (3 months ago) | See Below |
Future Estimates | Average of up to 8 Analyst Estimates (S&P Global) | See Below |
Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
---|---|---|---|---|
2022-12-31 | 3,258 | 167 | 1 | |
2021-12-31 | 2,981 | 205 | 147 | 7 |
2020-12-31 | 2,848 | 194 | 137 | 8 |
2019-12-31 | 2,726 | 175 | 121 | 8 |
2019-10-28 |
Date (Data in EUR Millions) | Revenue | Cash Flow | Net Income * |
---|---|---|---|
2019-06-30 | 2,636 | 139 | 111 |
2019-03-31 | 2,512 | 127 | 105 |
2018-12-31 | 2,389 | 114 | 100 |
2018-09-30 | 2,260 | 102 | 94 |
2018-06-30 | 2,131 | 90 | 88 |
2018-03-31 | 2,022 | 102 | 83 |
2017-12-31 | 1,912 | 114 | 77 |
2017-09-30 | 1,840 | 112 | 77 |
2017-06-30 | 1,768 | 110 | 76 |
2017-03-31 | 1,743 | 105 | 75 |
2016-12-31 | 1,718 | 100 | 73 |
2016-09-30 | 1,706 | 102 | 71 |
*GAAP earnings excluding extraordinary items.
Data Point | Source | Value |
---|---|---|
Past Financials | Company Filings (3 months ago) | See Below |
Future Estimates | Average of up to 8 Analyst Estimates (S&P Global) | See Below |
All data from IMCD Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
Date (Data in EUR Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
---|---|---|---|---|
2022-12-31 | ||||
2021-12-31 | 2.82 | 2.88 | 2.75 | 4.00 |
2020-12-31 | 2.60 | 2.86 | 2.47 | 5.00 |
2019-12-31 | 2.30 | 2.55 | 2.18 | 5.00 |
2019-10-28 |
Date (Data in EUR Millions) | EPS * |
---|---|
2019-06-30 | 2.11 |
2019-03-31 | 2.01 |
2018-12-31 | 1.91 |
2018-09-30 | 1.80 |
2018-06-30 | 1.68 |
2018-03-31 | 1.58 |
2017-12-31 | 1.47 |
2017-09-30 | 1.47 |
2017-06-30 | 1.46 |
2017-03-31 | 1.42 |
2016-12-31 | 1.39 |
2016-09-30 | 1.35 |
*GAAP earnings excluding extraordinary items.
How has IMCD performed over the past 5 years?
All data from IMCD Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
Date (Data in EUR Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
---|---|---|---|---|
2019-06-30 | 2,636.35 | 110.63 | 289.89 | |
2019-03-31 | 2,512.48 | 105.34 | 277.05 | |
2018-12-31 | 2,388.61 | 100.06 | 264.21 | |
2018-09-30 | 2,259.89 | 94.15 | 249.58 | |
2018-06-30 | 2,131.17 | 88.25 | 234.95 | |
2018-03-31 | 2,021.66 | 82.76 | 222.09 | |
2017-12-31 | 1,912.15 | 77.26 | 209.22 | |
2017-09-30 | 1,840.10 | 76.83 | 200.23 | |
2017-06-30 | 1,768.06 | 76.39 | 191.23 | |
2017-03-31 | 1,743.03 | 74.67 | 187.26 | |
2016-12-31 | 1,718.01 | 72.96 | 183.28 | |
2016-09-30 | 1,705.65 | 70.91 | 179.31 | |
2016-06-30 | 1,693.30 | 68.86 | 175.33 | |
2016-03-31 | 1,615.40 | 65.35 | 169.12 | |
2015-12-31 | 1,537.49 | 61.85 | 162.91 | |
2015-09-30 | 1,464.54 | 57.32 | 155.43 | |
2015-06-30 | 1,391.59 | 52.79 | 147.96 | |
2015-03-31 | 1,386.23 | 34.29 | 145.68 | |
2014-12-31 | 1,365.68 | 19.91 | 142.31 | |
2014-09-30 | 1,349.78 | 5.82 | 142.38 | |
2014-06-30 | 1,333.88 | -8.27 | 142.45 | |
2014-03-31 | 1,278.99 | -3.24 | 137.59 | |
2013-12-31 | 1,241.76 | -5.39 | 135.53 | |
2012-12-31 | 1,116.58 | -17.82 | 120.34 |
*GAAP earnings excluding extraordinary items.
How is IMCD's financial health and their level of debt?
All data from IMCD Company Filings, last reported 3 months ago.
Date (Data in EUR Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
---|---|---|---|
2019-06-30 | 813.60 | 797.99 | 114.44 |
2019-03-31 | 813.60 | 797.99 | 114.44 |
2018-12-31 | 786.35 | 695.88 | 85.16 |
2018-09-30 | 786.35 | 695.88 | 85.16 |
2018-06-30 | 739.29 | 574.46 | 68.22 |
2018-03-31 | 739.29 | 574.46 | 68.22 |
2017-12-31 | 729.18 | 552.09 | 61.38 |
2017-09-30 | 729.18 | 552.09 | 61.38 |
2017-06-30 | 713.57 | 453.23 | 54.12 |
2017-03-31 | 713.57 | 453.23 | 54.12 |
2016-12-31 | 722.06 | 455.26 | 56.50 |
2016-09-30 | 722.06 | 455.26 | 56.50 |
2016-06-30 | 680.80 | 483.60 | 65.34 |
2016-03-31 | 680.80 | 483.60 | 65.34 |
2015-12-31 | 653.83 | 495.54 | 56.55 |
2015-09-30 | 653.83 | 495.54 | 56.55 |
2015-06-30 | 637.52 | 480.45 | 47.06 |
2015-03-31 | 637.52 | 480.45 | 47.06 |
2014-12-31 | 530.81 | 326.98 | 59.97 |
2014-09-30 | 530.81 | 326.98 | 59.97 |
2014-06-30 | -65.19 | 892.61 | 45.07 |
2014-03-31 | -63.52 | 876.30 | 46.02 |
2013-12-31 | -67.05 | 863.40 | 38.10 |
2012-12-31 | -49.65 | 758.49 | 33.86 |
What is IMCD's current dividend yield, its reliability and sustainability?
Data Point | Source | Value |
---|---|---|
Past Annualized Dividend Yield | S&P Global Market Data | See Below |
Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
Future Dividends per Share Estimates | Average of up to 8 Analyst Estimates (S&P Global) | See Below |
United States of America Trade Distributors Industry Average Dividend Yield | Market Cap Weighted Average of 15 Stocks | 2.6% |
United States of America Market Average Dividend Yield | Market Cap Weighted Average of 1939 Stocks | 2.4% |
United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.5% |
United States of America Top 25% Dividend Yield | 75th Percentile | 3.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
Date (Data in €) | Dividend per Share (annual) | Avg. No. Analysts |
---|---|---|
2022-12-31 | 1.15 | 1.00 |
2021-12-31 | 1.08 | 7.00 |
2020-12-31 | 1.00 | 8.00 |
2019-12-31 | 0.90 | 8.00 |
2019-10-28 |
Date (Data in €) | Dividend per share (annual) | Avg. Yield (%) |
---|---|---|
2019-03-01 | 0.800 | 1.117 |
2019-02-28 | 0.800 | 1.159 |
2018-03-02 | 0.620 | 1.061 |
2017-05-10 | 0.550 | 1.080 |
2016-03-16 | 0.440 | 1.124 |
2015-03-11 | 0.200 | 0.610 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
Mr. Pieter C.J. van der Slikke, also known as Piet, has been Chief Executive Officer and Member of Management Board of IMCD N.V. since 1995. Mr. Slikke serves as the Chief Executive Officer at IMCD Group B.V. for IMCD Australia Limited, IMCD Malaysia SDN BHD and IMCD Benelux B.V. Mr. Slikke served as a Member of Board of Management at IMCD Group BV. He served as a Director of IMCD Group B.V. He started his career as an attorney at law at the law firm De Brauw Blackstone Westbroek in 1981 and practiced law in The Hague, Amsterdam and New York. In 1988 Mr Van der Slikke became General Counsel of Rotterdam-based Dutch conglomerate Internatio-Müller and in 1993 he was appointed as Group Director. As of 1995, when Internatio-Müller aggregated a number of chemical distribution businesses into a single division. He holds a law degree from the University of Groningen .
Average tenure and age of the IMCD management team in years:
Average tenure and age of the IMCD board of directors in years:
IMCD N.V. sells, markets, and distributes specialty chemicals, and pharmaceutical and food ingredients in Europe, the Middle East, Africa, the Asia-Pacific, and the Americas. The company offers detergent surfactants, builders, rheology modifiers, solubilizers, and functional additives; excipients, active pharmaceutical ingredients, specialty solvents, process chemicals, and intermediates for formulation and chemical synthesis; and personal care products, such as color cosmetics, dental products, deodorants, fragrances, hair and skin care chemicals, and toiletries. It also provides additives, fillers, pigments, resins, and specialty solvents to the coatings, paints, construction, adhesives, and inks industries; food ingredients and flavors, and nutrition products; automotive, fuel and refinery, and industrial lubricant additives; and synthesis products, including additives, catalysts, intermediates, monomers, processing aids, reactive diluents, solvents, and surface active agents. In addition, the company offers additives, functional fillers, pigments, polymers, compounds, and masterbatches; and other products. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Name: | IMCD N.V. |
IMCD.Y | |
Exchange: | OTCPK |
Founded: | 1995 |
€4,070,961,311 | |
52,445,613 | |
Website: | http://www.imcdgroup.com |
Address: |
IMCD N.V. Wilhelminaplein 32, Rotterdam, Zuid-Holland, 3072 DE, Netherlands |
Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
---|---|---|---|---|---|---|---|
ENXTAM | IMCD | Ordinary Shares | Euronext Amsterdam | NL | EUR | 27. Jun 2014 | |
OTCPK | IMDZ.F | Ordinary Shares | Pink Sheets LLC | US | USD | 27. Jun 2014 | |
DB | INX | Ordinary Shares | Deutsche Boerse AG | DE | EUR | 27. Jun 2014 | |
LSE | 0QVU | Ordinary Shares | London Stock Exchange | GB | EUR | 27. Jun 2014 | |
BATS-CHIXE | IMCDA | Ordinary Shares | BATS 'Chi-X Europe' | GB | EUR | 27. Jun 2014 | |
OTCPK | IMCD.Y | ADR | Pink Sheets LLC | US | USD | 10. May 2016 |
Trading Companies and Distributors | |
Capital Goods |
Area | Date (UTC time) |
---|---|
Company Analysis updated: | 2019/10/28 01:09 |
End of day share price update: | 2019/07/30 00:00 |
Last estimates confirmation: | 2019/10/22 |
Last earnings filing: | 2019/08/16 |
Last earnings reported: | 2019/06/30 |
Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.